PIK3CA-associated overgrowth spectrum disorders are a group of disorders caused by mutations in the PIK3CA gene located on chromosome 3q26.32, which encodes a component of phosphatidyl inositol 3-kinase (PI3K). These alterations result in activation of a signaling cascade pathway, which in turn causes uncontrolled cell growth and division. These conditions result in a variety of medical conditions, including but not limited to tumors, tissue hyperplasia, and phenomena such as Kleberg syndrome and other inherited syndromes. The effects of these mutations can manifest in early childhood or adulthood, causing a variety of clinical manifestations, making diagnosis and treatment of this disorder complex.
History of the disease and interesting historical facts
The history of studying PIK3CA mutations and related diseases dates back to the late 20th century, when scientists began to identify specific molecular changes in malignant tumor cells. In the 2000s, the study of the gн PIK3CA mutation gained particular popularity when its links to breast cancer, stomach cancer, and other localizations were noted. The discovery of PIK3CA mutations opened new horizons for understanding the pathogenesis of tumor diseases and created the prerequisites for the development of targeted therapies. Interestingly, some researchers note that PIK3CA mutations may also play an important role in metabolic dysfunctions, indicating their systemic impact.
Epidemiology
According to epidemiological studies, mutations in the PIK3CA gene are found in 25-40% cases of various cancers, which implies their significant involvement in the tumor process. For example, in breast cancer, the frequency of PIK3CA mutations can reach 30%. These mutations are also detected in patients with some hereditary syndromes, such as Phillips syndrome and Lindsay syndrome. Notably, the prevalence of mutations can vary depending on the ethnic group and geographic region, which further emphasizes the need for a multifactorial approach to studying these changes.
Genetic predisposition to this disease
Genetic predisposition to diseases associated with PIK3CA mutations is largely determined by inherited changes in this gene. There are different types of mutations, which can affect both single nucleotides and large fragments of the gene. The most common mutations in PIK3CA include p.H1047R, p.E545K, and p.E542K. Some of these mutations lead to increased PI3K-alpha activity, which promotes excessive cell growth and increases the likelihood of developing malignancies. Importantly, not all mutation carriers develop diseases, indicating that polygenic factors and the external environment influence the expression of mutations.
Risk factors for the development of this disease
Risk factors associated with diseases caused by PIK3CA mutations can be divided into several categories:
- Physical factors: Overweight and obesity, which can promote abnormal cell growth.
- Chemical factors: Exposure to carcinogens, including tobacco tar and some chemicals.
- Hormonal factors: Imbalances in hormone levels, especially estrogen, have been linked to some forms of cancer.
- Viral infections: Some viruses, such as HPV, can contribute to the development of cancer.
- Heredity: A family history of malignancy may indicate a genetic predisposition to PIK3CA mutations.
Diagnosis of this disease
Diagnosis of diseases associated with PIK3CA mutations is based on a comprehensive approach and includes several stages:
- Main symptoms: Clinical manifestations may vary depending on the type of disease, but often include an increase in the size of the tumor, pain, and changes in the function of the corresponding organs.
- Laboratory tests: Genetic testing to detect mutations in PIK3CA is a key test to confirm the diagnosis.
- Radiological examinations: Ultrasound, MRI, and CT are used to visualize tumor formations.
- Other types of disease diagnostics: A biopsy of neoplasms, which allows obtaining a tissue sample for histological examination.
- Differential diagnosis: It is important to rule out other possible causes of the disease, such as infections or benign tumors.
Treatment
Treatment of PIK3CA-associated diseases is a multi-tiered and often personalized approach depending on the type and stage of the disease:
- General treatment: Includes comprehensive symptom management and rehabilitation.
- Pharmacological treatment: PI3K inhibitors such as idilastam and others may be used in metastatic cancer associated with PIK3CA mutations.
- Surgical treatment: Operations to remove neoplasms in cases where it is possible and safe.
- Other types of treatment: Radiation therapy and immunotherapy may be used depending on the individual clinical case.
List of medications used to treat this disease
Drugs used to treat diseases associated with PIK3CA mutations include:
- Afeslinib
- Cortimomab
- Idilastat
- Tsinalgide
Disease monitoring
Monitoring of the condition and treatment of PIK3CA-related diseases includes regular examinations and monitoring of the patient's condition:
- Control stages: Periodic genetic tests and clinical examinations to assess tumor activity.
- Forecast: Prognosis depends on the overall disease stage assessment and response to treatment. Early detection of PIK3CA mutations can significantly improve outcome.
- Complications: Relapses of the disease, metastasis and other complications are possible, requiring careful monitoring and correction of therapy.
Age-related features of the disease
The course of diseases associated with PIK3CA mutations varies depending on age group:
- Childhood: Diseases can manifest through tissue hyperplasia and other growth abnormalities.
- Adolescence: More aggressive forms of the disease are often observed, requiring more intensive treatment.
- Adulthood: Often, a later onset of diseases and less pronounced manifestations in the initial stages are recorded.
- Old age: Older patients have an increased risk of co-morbidities, which can significantly complicate treatment.
Questions and Answers
- What is a PIK3CA mutation? This is a change in the PIK3CA gene that leads to increased PI3K activity and can cause the development of malignant tumors.
- How are PIK3CA-related diseases diagnosed? Diagnosis includes genetic tests, radiological methods and biopsy to confirm the presence of mutations.
- What are the main treatment methods? Treatment may include drugs, surgery, and radical therapies such as immunotherapy.
- What is the prognosis for people with a PIK3CA mutation? The prognosis depends on the type and stage of the disease, but early detection can significantly improve the outcome of therapy.
- Does age affect the course of the disease? Yes, different age groups may show differences in the manifestations and severity of diseases associated with PIK3CA mutation.
